PLUS THERAPEUTICS, INC. — Director's Dealing 2013

Jan 3, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2013-01-01

Reporting Person: Hawkins Richard J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-01-01	Restricted Stock Award (Common Stock)	A	6100	—	Acquired	6100	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-01	Non-Qualifed Stock Option (Right to Buy)	$2.80	A	6100	Acquired	2023-01-01	Common Stock (6100)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20085	Direct

Footnotes

F1: The Restricted Stock Award vests in full on January 1, 2014, subject to the terms of the Company's 2004 Equity Incentive Plan.

F2: The option vests 1/24th per month from date of grant, subject to the terms of the Company's 2004 Equity Incentive Plan.